Eric Schmidt - Cantor Fitzgerald Analyst Performance This page shows the methodology used to calculate Eric Schmidt's recommendation performance. Listed below are links to the research notes issued, the price targets issued by the analyst, and the stock's actual price 12 months from the date the research note was issued. These rankings are based on research reports from . Rankings are updated daily. MarketBeat Analyst Ranking: Subscribe to MarketBeat All Access for the recommendation accuracy ratingAverage 12-Month ROI of Buy and Strong Buy Recommendations: ???% Export to Excel CompanyReport DateReport Date Price12-MonthPrice TargetRating12-MonthActual Price12-MonthROIDetailsSRRKScholar Rock7/17/2025$41.15Overweight???%???%RNAAvidity Biosciences6/27/2025$29.83$96.00Overweight???%???%IMTXImmatics4/1/2025$4.23Overweight???%???%GLYCGlycoMimetics3/21/2025$0.27Overweight???%???%SMMTSummit Therapeutics3/21/2025$19.44Overweight???%???%ALMSAlumis3/20/2025$4.33Overweight???%???%ADCTADC Therapeutics3/7/2025$1.84Overweight???%???%PRTAProthena2/21/2025$15.78Overweight???%???%CRSPCRISPR Therapeutics2/19/2025$53.38Neutral???%???%CDTXCidara Therapeutics1/27/2025$19.51Overweight???%???%INCYIncyte1/10/2025$70.17Neutral???%???%IONSIonis Pharmaceuticals1/6/2017$47.83Hold???%???%ALXNAlexion Pharmaceuticals12/12/2016$132.07$180.00Buy???%???%EXELExelixis11/8/2016$12.36Outperform???%???%BPMCBlueprint Medicines11/3/2016$28.02Buy???%???%AGIOAgios Pharmaceuticals11/3/2016$47.63Buy???%???%RGLSRegulus Therapeutics11/2/2016$2.80Market Perform???%???%BIIBBiogen10/26/2016$286.00$368.00Buy???%???%KITE(KITE)10/19/2016$49.66Buy???%???%BMYBristol Myers Squibb10/18/2016$99.64$150.00Outperform???%???%INCYIncyte10/12/2016$92.11Outperform???%???%EXELExelixis10/12/2016$12.69Outperform???%???%BGNEBeiGene10/7/2016$31.79Buy???%???%MDVN(MDVN)9/28/2016$81.44Hold???%???%ALXNAlexion Pharmaceuticals9/22/2016$130.36Buy???%???%AMGNAmgen9/19/2016$171.38Buy???%???%BMYBristol Myers Squibb9/12/2016$106.85$150.00Outperform???%???%BMYBristol Myers Squibb8/25/2016$110.60$150.00Outperform???%???%IONSIonis Pharmaceuticals8/13/2016$35.03Market Perform???%???%BMYBristol Myers Squibb8/10/2016$113.80$150.00Buy???%???%EXELExelixis8/10/2016$10.87Buy???%???%BPMCBlueprint Medicines8/9/2016$23.76Buy???%???%RAREUltragenyx Pharmaceutical8/9/2016$64.97Buy???%???%EBSEmergent Biosolutions8/7/2016$29.78$33.00Hold???%???%MACKMerrimack Pharmaceuticals8/5/2016$5.92Market Perform???%???%IONSIonis Pharmaceuticals8/3/2016$37.74Buy???%???%BMYBristol Myers Squibb7/28/2016$108.11$150.00Buy???%???%RAREUltragenyx Pharmaceutical7/15/2016$49.54Buy???%???%IONSIonis Pharmaceuticals7/14/2016$24.68Hold???%???%EBSEmergent Biosolutions6/22/2016$39.32Market Perform???%???%KITE(KITE)6/20/2016$51.09Buy???%???%ALXNAlexion Pharmaceuticals6/8/2016$138.88Buy???%???%RGLSRegulus Therapeutics6/8/2016$5.31Buy???%???%EXELExelixis6/7/2016$7.12Outperform???%???%KITE(KITE)6/6/2016$57.42Buy???%???%BGNEBeiGene6/6/2016$33.11Buy???%???%RLYP(RLYP)5/29/2016$18.06Buy???%???%IONSIonis Pharmaceuticals5/26/2016$21.36Hold???%???%BIIBBiogen5/26/2016$282.00Buy???%???%AGIOAgios Pharmaceuticals5/24/2016$48.58Buy???%???%EXELExelixis5/24/2016$6.15Buy???%???%CCXIChemoCentryx5/19/2016$4.37Hold???%???%AGIOAgios Pharmaceuticals5/18/2016$50.51Buy???%???%BGNEBeiGene5/12/2016$28.19Buy???%???%ANACArctos NorthStar Acquisition5/10/2016$68.98Buy???%???%BPMCBlueprint Medicines5/10/2016$15.36Buy???%???%PBYIPuma Biotechnology5/7/2016$23.49Market Perform???%???%XNPT(XNPT)5/6/2016$4.14Hold???%???%IONSIonis Pharmaceuticals5/4/2016$35.25Buy???%???%MACKMerrimack Pharmaceuticals5/3/2016$7.28Buy???%???%INCYIncyte5/3/2016$74.36Buy???%???%RGLSRegulus Therapeutics5/2/2016$5.93Buy???%???%BMYBristol Myers Squibb4/28/2016$106.15Buy???%???%ALXNAlexion Pharmaceuticals4/28/2016$142.53Buy???%???%RLYP(RLYP)4/17/2016$18.56Buy???%???%XNPT(XNPT)4/17/2016$4.94Hold???%???%MACKMerrimack Pharmaceuticals4/17/2016$7.97Buy???%???%MDVN(MDVN)4/17/2016$51.17Hold???%???%INCYIncyte4/17/2016$77.78Buy???%???%EXELExelixis4/17/2016$4.35Buy???%???%EBSEmergent Biosolutions4/17/2016$39.60Buy???%???%BIIBBiogen4/17/2016$268.50Buy???%???%ANACArctos NorthStar Acquisition4/17/2016$64.71Buy???%???%AMGNAmgen4/17/2016$160.13Buy???%???%ALXNAlexion Pharmaceuticals4/17/2016$153.09Buy???%???%BMYBristol Myers Squibb4/12/2016$103.81$150.00Outperform???%???%INCYIncyte4/6/2016$81.87Buy???%???%PBYIPuma Biotechnology3/28/2016$35.37Hold???%???%BMYBristol Myers Squibb3/16/2016$97.98$150.00Outperform???%???%CCXIChemoCentryx3/14/2016$3.48Hold???%???%AMGNAmgen3/8/2016$147.31$193.00Outperform???%???%INCYIncyte3/7/2016$71.99Buy???%???%ANACArctos NorthStar Acquisition3/1/2016$63.78Outperform???%???%EXELExelixis3/1/2016$3.64Buy???%???%XNPT(XNPT)2/26/2016$4.38Hold???%???%RLYP(RLYP)2/25/2016$16.78Buy???%???%AMGNAmgen2/22/2016$148.56$193.00Outperform???%???%EXELExelixis2/2/2016$4.43Buy???%???%AMGNAmgen1/28/2016$152.73Buy???%???%BIIBBiogen1/27/2016$259.87Buy???%???%BIIBBiogen1/4/2016$306.35$368.00Buy???%???%BMYBristol Myers Squibb12/29/2015$119.10Buy???%???%BMYBristol Myers Squibb12/23/2015$111.14$150.00Buy???%???%BMYBristol Myers Squibb11/5/2015$120.46$150.00Outperform???%???%KITE(KITE)11/3/2015$72.33Outperform???%???%BIIBBiogen10/22/2015$276.34$368.00Outperform???%???%EXELExelixis9/28/2015$5.91Buy???%???%BIIBBiogen9/20/2015$314.67Buy???%???%INCYIncyte9/16/2015$131.47Buy???%???%BIIBBiogen8/25/2015$278.23$494.00Buy???%???%INCYIncyte8/17/2015$114.60Outperform???%???%KITE(KITE)8/16/2015$58.00Buy???%???%AMGNAmgen8/12/2015$170.62$193.00Buy???%???%BMYBristol Myers Squibb8/11/2015$130.66$150.00Outperform???%???%BIIBBiogen8/5/2015$330.38$494.00Outperform???%???%BIIBBiogen7/22/2015$391.74$494.00Buy???%???%BMYBristol Myers Squibb7/22/2015$138.29$146.00Outperform???%???%INCYIncyte7/22/2015$114.42Outperform???%???%BPMCBlueprint Medicines7/13/2015$28.02Buy???%???%INCYIncyte6/25/2015$105.29Buy???%???%KITE(KITE)6/24/2015$61.29Outperform???%???%INCYIncyte6/11/2015$106.11Buy???%???% Return to Analyst Rankings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
